Misonix buys Solsys Medical for $97mm plus net debt; acquisition closes at $109mm
Misonix Inc. penned a definitive agreement to acquire privately held regenerative medicine firm Solsys Medical LLC in an all-stock transaction. Misonix will issue approximately 5.7mm new shares valued at $97mm (based on the market average), and will also assume $20mm in outstanding secured debt.
- Medical Devices
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com